grn300
greenfire bio
['grn300 ', 'ovarian', 'greenfirebio']
#greenfirebio to update progress on phase 1 clinical trial for #sik2 #sik3 #inhibitor, #grn300 in #ovariancancer at the #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.